Hudson Bay Capital Management’s Revolution Medicines RVMD Stock Holding History

Hudson Bay Capital Management’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.34M	Sell	12,500 -7,560	-38%	-$1.1M	0.01%	782
2026 Q1	$1.95M	Buy	+20,060	New	+$2.03M	0.01%	772
2025 Q3	–	Sell	-30,550	Closed	-$1.12M	–	1624
2025 Q2	$1.12M	Buy	+30,550	New	+$1.17M	﹤0.01%	939
2023 Q4	–	Sell	-43,095	Closed	-$1.19M	–	870
2023 Q3	$1.19M	Sell	43,095 -198,905	-82%	-$5.9M	0.01%	541
2023 Q2	$6.47M	Buy	+242,000	New	+$5.94M	0.05%	262

Other funds holding RVMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Hudson Bay Capital Management's RVMD Position: Q2 2026 in Review

Hudson Bay Capital Management reduced its Revolution Medicines (RVMD) stake by 38% in Q2 2026, selling an estimated $1.1M and leaving 12,500 shares worth $2.34M. The position accounts for 0.01% of the portfolio, ranked #782.

Hudson Bay Capital Management first reported a position in RVMD in Q2 2023 and has held it in 5 quarters since. The position peaked at $6.47M in Q2 2023. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

Hudson Bay Capital Management held 12,500 shares of Revolution Medicines worth $2.34M as of Q2 2026.
Hudson Bay Capital Management sold 7,560 Revolution Medicines shares in Q2 2026, an estimated $1.1M.
Revolution Medicines made up 0.01% of Hudson Bay Capital Management's portfolio in Q2 2026, its #782 holding.
Hudson Bay Capital Management first reported a position in Revolution Medicines in Q2 2023 and has held it in 5 quarters since.
Hudson Bay Capital Management's Revolution Medicines position peaked at $6.47M in Q2 2023.
690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.